The VA Medical Center in North Las Vegas says they are the first hospital in the region to offer a new kind of testing.

Emergen Research Logo The DNA Testing market is expected to grow from an estimated USD 12.51 billion in 2024 to USD 81.82 billion in 2033, ...

MyRisk Hereditary Cancer Test: This is a DNA sequencing test for assessing ... As you can see, Pharmacogenomics provided the fastest sales growth during the quarter. This was a result of rising ...

If a pharmacogenomic test result can significantly impact on ... practices for prospective systematic collection and storage of DNA for genotyping of all study subjects enrolled in randomized ...

Know about the revolutionary therapies, personalised medicine and cancer treatments that are changing the game!

BioAro, a global leader in precision health and genomics, will unveil its groundbreaking AI-powered PanOmiQ platform at the ...

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have earned a consensus recommendation of “Hold” from the fourteen analysts that are covering the company, MarketBeat reports. Three ...

KBC Group NV raised its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 132.8% in the fourth quarter, ...

Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...